Polymer films

US9408916B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9408916-B2
Application numberUS-201414491813-A
CountryUS
Kind codeB2
Filing dateSep 19, 2014
Priority dateSep 19, 2013
Publication dateAug 9, 2016
Grant dateAug 9, 2016

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Biodegradable, cross-linked polymer films and methods of making the same are described. The polymer films can be used for preventing adhesions following surgery and/or delivering therapeutic agents.

First claim

Opening claim text (preview).

We claim: 1. A polymer film comprising: at least one monomer including at least one functional group; and at least one crosslinker selected from bis-glycidyl amino alcohol, bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate, wherein a, b, c, d, e, and f are each independently 1-20; wherein the polymer film has a thickness between about 40 μm and about 1,200 μm and is biodegradable. 2. The polymer film of claim 1 , wherein the polymer film has a shape selected from a circle, square, rectangle, triangle, ellipse, or pentagon. 3. The polymer film of claim 1 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide. 4. The polymer film of claim 1 , wherein the at least one monomer includes an ionizable functional group. 5. The polymer film of claim 4 , wherein the ionizable functional group is basic. 6. The polymer film of claim 4 , wherein the ionizable functional group is acidic. 7. The polymer film of claim 1 , wherein the at least one crosslinker includes at least two functional groups. 8. The polymer film of claim 1 , wherein the crosslinker includes at least one linkage susceptible to degradation through hydrolysis or enzymatic action. 9. The polymer film of claim 8 , wherein the at least one linkage is an ester, a thioester, a carbonate, a carbamate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenase, a peptide cleavable by matrix elastase, a peptide cleavable by matrix cathepsin, or a combination thereof. 10. The polymer film of claim 9 , including a second crosslinker including a second linkage selected from an ester, a thioester, a carbonate, a carbamate, a peptide cleavable by matrix metalloproteinases, a peptide cleavable by matrix collagenases, a peptide cleavable by matrix elastases, and a peptide cleavable by matrix cathepsins. 11. The polymer film of claim 1 , wherein the polymer film is substantially degraded within about 6 months of implantation. 12. The polymer film of claim 1 , wherein the polymer film is substantially degraded within about 1 month of implantation. 13. The polymer film of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bis-glycidyl amino alcohol. 14. The polymer film of claim 1 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate. 15. A method of making a polymer film comprising: reacting a prepolymer solution including at least one monomer including at least one functional group, at least one crosslinker susceptible to degradation, and an initiator; and forming the polymer film, wherein the polymer film has a thickness between about 40 μm and about 1,200 μm, wherein the at least one crosslinker is selected from bis-glycidyl amino alcohol, bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate, wherein a, b, c, d, e, and f are each independently 1-20. 16. The method of claim 15 , wherein the film is formed between two plates including at least one spacer. 17. The method of claim 15 , wherein the initiator is N,N,N′,N′-tetramethylethylenediamine. 18. The method of claim 15 , wherein the polymer film has a shape selected from a circle, square, rectangle, triangle, ellipse, or pentagon. 19. The method of claim 15 , wherein the at least one functional group is acrylate, acrylamide, methacrylate, or methacrylamide. 20. The method of claim 15 , wherein the polymer film is biodegradable. 21. The method of claim 20 , wherein the polymer film is substantially degraded within about 1 month of implantation. 22. The method of claim 20 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bis-glycidyl amino alcohol. 23. The method of claim 20 , wherein the at least one monomer is acrylamide and the at least one crosslinker is bi-functionalized methacryloyl-Ala-Pro-Gly-Leu-AEE-methacrylate.

Assignees

Inventors

Classifications

  • Materials at least partially resorbable by the body · CPC title

  • A61K47/32Primary

    Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title

  • C08F120/56Primary

    Acrylamide; Methacrylamide · CPC title

  • of esters containing halogen, nitrogen, sulfur, or oxygen atoms in addition to the carboxy oxygen · CPC title

  • Acrylamide; Methacrylamide · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9408916B2 cover?
Biodegradable, cross-linked polymer films and methods of making the same are described. The polymer films can be used for preventing adhesions following surgery and/or delivering therapeutic agents.
Who is the assignee on this patent?
Microvention Inc
What technology area does this patent fall under?
Primary CPC classification A61K47/32. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Aug 09 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 3 related publications on this page (citations in our corpus or others sharing the same primary CPC).